Board of Directors
Mr. Rash, a co-founder of American Pathology Partners, has over 25 years of experience in healthcare services. Mr. Rash is Chairman and CEO of RegionalCare Hospital Partners, a hospital company backed by New York-based Warburg Pincus. Previously he was Chairman and CEO of Province Healthcare, a $1 billion NYSE company that owned 21 hospitals and managed more than 50 facilities. Mr. Rash founded Province as a start-up in 1996 backed by Chicago-based GTCR. Province was acquired in 2004 by Lifepoint Hospitals, Inc. (NASDAQ: LPNT) for $1.7 billion.
Prior to his tenure at Province Healthcare, Mr. Rash served as Executive Vice President and Chief Operating Officer for Community Health Systems ((NYSE: CYH) where he led the growth of the company from 10 to 41 hospitals in 17 states. Earlier career, Mr. Rash worked at numerous community hospitals in various administrative and financial roles.
Mr. Rash's experience and leadership includes membership on the development team of the largest hospice company in the country and a long-term board seat on the largest Medicare Advantage program in the U.S. Mr. Rash is a past chairman and one of the co-founders of the Federation of American Hospitals and has also served as Chairman of the Nashville Healthcare Council. He holds both a bachelorís degree and MBA from Middle Tennessee State University.
Mr. Abbasi has over 20 years of experience in healthcare services, including diagnostic imaging and surgery centers. Most recently, Mr. Abbasi was Chairman and Chief Executive Officer of National Surgical Care, Inc., Dallas, Texas, a venture-backed surgery center company that owned and operated 22 surgery centers in 11 states in partnership with over 400 physicians, generating $140 million of revenue. The company was acquired by Nashville-based AmSurg Corp. in 2011.
Prior to National Surgical Care, Mr. Abbasi served as President and Chief Executive Officer of Radiologix, Inc., a leading national provider of diagnostic imaging services. Mr. Abbasi co-founded Radiologix in 1996 and was instrumental in building the company from a creative idea to one of the nation's leading providers of diagnostic imaging services, with 70 outpatient imaging centers in seven states, 2,200 employees, over 300 affiliated radiologists and $250 million in revenue. He led Radiologix through its IPO in November 1997 and its sale to RadNet, Inc. in 2006.
Mr. Abbasi previously served as Chief Operating Officer and Chief Financial Officer of Adminiquest, Inc., a web-enabled, full-service outsourcing solutions provider to the insurance and benefits industry. Mr. Abbasi also was a Vice President in the Health Care Group of Robertson Stephens, Inc., with responsibility for investment banking business development and the execution of a broad range of corporate finance and M&A transactions. In addition, he has held various positions at Citigroup Inc., including Vice President and Senior Industry Analyst in the Health Care Group.
Mr. Abbasi also serves as Director and Chairman of the Audit Committee for Behringer Harvard Multifamily REIT I, Inc; as well as Director for American CareSource Holdings, Inc. (AMEX: XSI). Mr. Abbasi earned BA in economics from the University of Pennsylvania and an MBA from the University of Rochester.
Dr. Gottlieb is currently a practicing physician and Resident Fellow at the American Enterprise Institute (AEI), a private, nonpartisan, not-for-profit institution dedicated to research and education on issues of government, economics and social welfare.
From 2005-2007, Dr. Gottlieb served as FDA Deputy Commissioner and before that, from 2003-2004, as a senior advisor to FDA Commissioner Mark McClellan and as the FDAís Director of Medical Policy Development. He left FDA in the spring of 2004 to work on implementation of the new Medicare Drug Benefit as a Senior Adviser to the Administrator of Medicare and Medicaid Services, where he supported the agency's policy work on quality improvement and coverage and payment decision-making, particularly related to new medical technologies.
Dr. Gottlieb is the author of more than 300 articles that have appeared in leading medical journals as well as The Wall Street Journal, The York Times, USA Today and Forbes Magazine. Dr. Gottlieb has held editorial positions on the British Medical Journal and the Journal of the American Medical Association and appears regularly as a guest commentator on the cable financial news channel CNBC.
Dr. Gottlieb, a graduate of Wesleyan University and Mount Sinai School of Medicine, completed his residency in internal medicine at the Mount Sinai Hospital and currently practices medicine as an attending physician at Stamford Hospital in Connecticut.
Mr. Makhzoumi is currently a Partner at New Enterprise Associates (NEA) which he joined in 2005 to focus on investments in the healthcare services and healthcare information technology arenas. Mr. Makhzoumi serves on the Board of Directors for American Pathology Partners, Elements Behavioral Health, and Nova Medical Centers. He is also a Board Observer at BENU, Bravo Health, Simplex Healthcare and Vantage Oncology. In the past, Mr. Makhzoumi has also worked closely with CHG Healthcare Services and ppoNEXT.
Prior to joining NEA, Mr. Makhzoumi was an Associate with Summit Partners, Boston, Massachusetts, where he was one of 50 principals responsible for investing and managing over $5.5 billion of capital. Mr. Makhzoumi focused on growth equity investments ranging from $15 Ė 300 million, including Summitís investment in Global Cash Access (NYSE: GCA).
Previously, Mr. Makhzoumi worked with UBS Investment Bank where he was a member of the inaugural class for the UBS Los Angeles office as an investment banker in the financial sponsors and leveraged finance groups. Mr. Makhzoumi also interned as a summer analyst with the NEA healthcare team, focusing on investments in healthcare services, healthcare IT and medical devices.
Mr. Makhzoumi currently serves as a founding board member of the Lance Armstrong Foundationís Young Leadership Cancer Council. He received a Bachelor's degree, with distinction, in international relations from the University of Pennsylvania.
Mr. Whitney is founder and Managing Member of Whitney Capital LLC, a private equity investment firm focused primarily on healthcare services and products and is also a Venture Advisor at New Enterprise Associates (NEA) where he focuses on healthcare investments. He currently serves as Chairman of Elements Behavioral Health, and a Board member of American Pathology Partners, Simplex Healthcare, and CHG Healthcare Services.
Mr. Whitney has also served Senior Advisor to the Chairman & CEO of DaVita, Inc. (NYSE: DVA), a Fortune 500 company, where he advised on and negotiated the $4.4 billion acquisition of HealthCare Partners and the $3.1 billion acquisition of the U.S. operations of Gambro Healthcare. Previously, Mr. Whitney was Executive Chairman of Specialty Laboratories, Inc. where he led the turnaround and successful sale of the company to AmeriPath, Inc.
Mr. Whitney has also served on two separate occasions (2000-2004 and 2008-2011) as Chief Financial Officer of DaVita. During his initial tenure he was a lead executive in the companyís financial and operating turnaround which created over $3 billion of equity value for investors, while during his second stint he oversaw an additional almost $4 billion of equity value creation.
Mr. Whitney earned a BS in business administration from Pennsylvania State University and an MBA from Harvard Business School.
| Back to Top |